Psoriasis and associated risk factors: a cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health
Carregando...
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC MEDICA BRASILEIRA
Autores
Citação
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, v.69, n.6, article ID e20230038, 7p, 2023
Resumo
OBJECTIVE: This study investigated the association of psoriasis with cardiovascular risk factors and psychological aspects among participants of theMETHODS: This is a cross-sectional study from the baseline data of the Brazilian Longitudinal Study of Adult Health cohort, collected between 2008 and retired civil servants from college and research institutions, aged between 35 and 74 years. Exclusion criteria included the intention to quit working at the institution, pregnancy, severe cognitive impairment, and, if retired, residence outside of a study center's corresponding area. Psoriasis case identification was based on a previous medical diagnosis of psoriasis. Cardiovascular risk profile, psychological aspects, and sociodemographic variables were investigated.RESULTS: Data from 15,105 participants were analyzed (mean age of 52.3 years, 51.3% women). The prevalence of psoriasis was 1.6% (n=236). Psoriasis was associated with higher education (OR 1.94 [CI 1.07-3.52]), health insurance plan (OR 1.56 [CI 1.08-2.25]), central obesity (OR 1.63 [CI 1.10-2.40]), smoking status (former OR 1.40 [CI 1.03-1.88]; current OR 1.61 [CI 1.08-2.40]), and very bad self-perception of health (OR 7.22 [CI 2.41-21.64]), remaining significant even after multivariate adjustment. Self-reported Black participants were less likely to have psoriasis (ORCONCLUSION: In a sample of healthy workers, psoriasis was associated with central obesity, smoking, and a very bad self-perception of health, which may contribute to future cardiovascular disease.
Palavras-chave
Psoriasis, Cardiovascular risk factors, Central obesity, Smoking, Self-perception
Referências
- Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
- Bakhtiyari M, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-05536-w
- Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780
- Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103
- DiBonaventura M, 2018, AN BRAS DERMATOL, V93, P197, DOI 10.1590/abd1806-4841.20186069
- Dowlatshahi EA, 2014, J INVEST DERMATOL, V134, P1542, DOI 10.1038/jid.2013.508
- Dowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131
- Abrahao-Machado ECF, 2020, AN BRAS DERMATOL, V95, P150, DOI 10.1016/j.abd.2019.07.004
- Gelfand JM, 2005, J AM ACAD DERMATOL, V52, P23, DOI 10.1016/j.jaad.2004.07.045
- Jalenques I, 2022, ACTA DERM-VENEREOL, V102, DOI 10.2340/actadv.v102.1386
- LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415
- Liang SE, 2019, J AM ACAD DERMATOL, V80, P1460, DOI 10.1016/j.jaad.2019.01.025
- Meneguin S, 2020, BMC DERMATOL, V20, DOI 10.1186/s12895-020-00116-9
- Mill JG, 2013, REV SAUDE PUBL, V47, P54, DOI 10.1590/S0034-8910.2013047003851
- Mosca S, 2015, INT J CARDIOL, V178, P191, DOI 10.1016/j.ijcard.2014.10.092
- Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339
- Romiti R, 2017, INT J DERMATOL, V56, pE167, DOI 10.1111/ijd.13604
- Rzeszutek M, 2021, QUAL LIFE RES, V30, P181, DOI 10.1007/s11136-020-02621-3
- Singh S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181039
- Solovan C, 2014, EUR J DERMATOL, V24, P242, DOI 10.1684/ejd.2014.2295
- Staniak HL, 2014, ATHEROSCLEROSIS, V237, P847, DOI 10.1016/j.atherosclerosis.2014.11.004
- Vie TL, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2019.100364
- Zhou H, 2020, J INT MED RES, V48, DOI 10.1177/0300060520964024